Physician profile
Steven Cummings
NPI 1336185636
$985.72
in general payments reported to CMS, 2019-2025
9 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $230 · 2021: $167 · 2022: $48.96 · 2023: $124 · 2024: $57.03 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $459.77 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Baxter Healthcare | $142.04 | 2020 | |
| W. L. Gore & Associates, INC. | $125.85 | 2019 | |
| Biom'Up Sa | $75.76 | 2019 | |
| Atricure, INC. | $54.24 | 2021 | |
| Corcym INC | $50.93 | 2023 | Perceval |
| Medtronic, INC. | $41.12 | 2023 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $19.09 | 2020 | |
| Angiodynamics, INC. | $16.92 | 2025 | Angiovac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Cummings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.